Prefillable inhaler

Services for the development of inhalation drugs: Our team have over 30 years of experience supporting our clients' product development for orally inhaled or nasal drug products (OINDP). This includes formulation, stability, testing, product performance testing, in vitro bioequivalence studies, CMC...

Inhalers which gives relief from Nasal Congestion and makes easier the breathing process.

Access the delivery technology best suited to the needs of your development programme, including unit-dose and multi-unit dose DPIs, pMDIs and smart nebulisers, suitable for home or hospital applications.

Dry Powder Inhalers:
Options include proprietary unit- and multi-unit dose platforms, as w...

The Resyca soft mist inhaler is a joint venture between Recipharm and Medspray and uses proprietary spray nozzle technology to deliver next-generation SMIs that deliver an aerosol from a liquid solution.

At Hovione we can tailor-make particle size distributions through complex particle engineering technologies, like wet-polishing and monosep, in ranges suitable for inhalation and incorporate desired morphology characteristics into your API. We are also able to start with a Hovione-produced API and develop ...

EMPOWERING SOLUTIONS TO SUPPLY MEDICATIONS We can produce a broad range of products for the drug-delivery market with our technical expertise and a focus on quality.
WE UNDERSTAND DRUG DELIVERY MARKET NEEDS
Proven Quality Management System Our company-wide quality management system ensures your...

Nemera has a recognized expertise in the development and manufacturing of respiratory drug delivery devices, such as Dry Powder Inhalers (DPIs), pressurized Metered Dose Inhalers (pMDIs) and dose counters.

More than ten million asthmatics rely everyday on devices manufactured by Nemera.

With nearly +125 years of capsule manufacturing experience, and the introduction of several capsule innovations to the pharmaceutical market, specifically in the field of inhaled drug delivery, Qualicaps® offers a broad portfolio of capsules specially designed for inhaled drug delivery, with superior a...

1.25 µg (Asthma)/ 2.5 µg (COPD) soft mist inhaler | Therapeutic use: Asthma/ Chronic obstructive pulmonary disease (COPD) | ATC: R03BB04

PERLAMED™ - BLISTair is a smart inhalation device. It is a patented, disposable, single-use Dry Powder Inhaler, made out of a high barrier primary packaging film. It is a platform for the pulmonarydelivery of a wide range of drugsubstances. The device is easy to use.

Development of nasal drugs: Scientists from our nasal drug development team provide method development, validation, and testing services to help you optimise the performance of your aqueous, powder, and propellant-driven nasal drug products. Conducted in Good Manufacturing Compliant (GMP) laborato...

Intertek Melbourn have been supporting clients’ product development for nearly 30 years across all classes of inhaled and nasal delivery technologies including nebulized therapeutics. We provide expert OINDP formulation development, product performance testing and analysis, in vitro bioequivalence studies,...

It gives relief from Asthama and breathlessness 

Our dry powder inhalers are derived from the commercially-validated AirFluSal® Gyrohaler® platform, but with a range of user interfaces and payload volumes, giving you confidence of performance and a proven regulatory track record.

With options for proprietary unit- and multi-unit dose platforms...

The plus10 DataCollector provides a high-performance data infrastructure for the acquisition and pre-processing of machine data from any source such as sensors, machine or robot controllers. Its simple configuration and implementation transforms machine data into Big Data and creates value through high-fre...